Luciana Tamie Kato Morinaga

Luciana Tamie Kato Morinaga

Auto-generated profile, based on publicly available information

Luciana Tamie Kato Morinaga

Heart Institute, University of Sao Paulo Medical School; Sirio Libanes Hospital

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ENElnara Marcia Negri
Elnara Marcia Negri
BPBruna Mamprim Piloto
Bruna Mamprim Piloto
LMLuciana Kato Morinaga
Luciana Kato Morinaga
CJCarlos Viana Poyares Jardim
Carlos Viana Poyares Jardim
SLShari Anne El-Dash Lamy
Shari Anne El-Dash Lamy
DDDaniel Deheinzelin
Daniel Deheinzelin
INTRODUCTION: Elevated D-dimer is a predictor of severity and mortality in COVID-19 patients and heparin use during in-hospital stay has been associated with decreased mortality. COVID-19 patient autopsies have revealed thrombi in the microvasculature, suggesting intravascular coagulation as a prominent feature of organ failure in these patients. Interestingly, in COVID-19, pulmonary compliance is preserved despite severe hypoxemia corroborating the hypothesis that perfusion mismatch may play a significant role in the development of respiratory failure. METHODS: We describe a series of 27 consecutive COVID-19 patients admitted to Sirio-Libanes Hospital in São Paulo-Brazil and treated with heparin in therapeutic doses tailored to clinical severity. RESULTS AND DISCUSSION: PaO2/FiO2 ratio increased significantly over the 72 hours following the start of anticoagulation, from 254(±90) to 325(±80), p=0.013, and 81% of the patients were discharged home within a mean time of 11.4 (±7.9) days. Most mechanically ventilated patients (67%) were extubated within 12.5(± 5.7) days. There were no bleeding complications or fatal events. Even though this uncontrolled case series does not offer absolute proof of DIC as the underlying mechanism of respiratory failure in COVID-19, patient’s positive response to tailored dose heparinization contributes to the understanding of the pathophysiological mechanism of the disease and provides valuable information for the treatment of these very sick patients while we await the results of further prospective controlled studies.

1 May 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
CJCarlos Vianna Poyares Jardim
Carlos Vianna Poyares Jardim
JJJosé Leonidas Alves Jr
José Leonidas Alves Jr
FOFrancisca Alexandra Gavilanes Oleas
Francisca Alexandra Gavilanes Oleas
LMLuciana Tamie Kato Morinaga
Luciana Tamie Kato Morinaga
RSRogério de Souza
Rogério de Souza
Acute pulmonary thromboembolism (APTE) is a highly prevalent condition (104-183 cases per 100,000 person-years) and is potentially fatal. Approximately 20% of patients with APTE are hypotensive, being considered at high risk of death. In such patients, immediate lung reperfusion is necessary in order to reduce right ventricular afterload and to restore hemodynamic stability. To reduce pulmonary vascular resistance in APTE and, consequently, to improve right ventricular function, lung reperfusion strategies have been developed over time and widely studied in recent years. In this review, we focus on advances in the indication and use of systemic thrombolytic agents, as well as lung reperfusion via endovascular and classical surgical approaches, in APTE.

1 January 2019 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
CMCarlos Henrique Miranda
Carlos Henrique Miranda
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
CJCarlos Vianna Poyares Jardim
Carlos Vianna Poyares Jardim
JJJosé Leonidas Alves Jr
José Leonidas Alves Jr
FOFrancisca Alexandra Gavilanes Oleas
Francisca Alexandra Gavilanes Oleas
RSRogério de Souza
Rogério de Souza

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
WSWillian Salibe-Filho
Willian Salibe-Filho
MTMario Terra-Filho
Mario Terra-Filho
CJCarlos Vianna Poyares Jardim
Carlos Vianna Poyares Jardim
RSRogerio de Souza
Rogerio de Souza
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension (PH) that arises from obstruction of the pulmonary vessels by recanalized thromboembolic material. CTEPH has a wide range of radiologic presentations. Commonly, it presents as main pulmonary artery enlargement, peripheral vascular obstructions, bronchial artery dilations, and mosaic attenuation patterns. Nevertheless, other uncommon presentations have been described, such as lung cavities. These lesions may be solely related to chronic lung parenchyma ischemia but may also be a consequence of concomitant chronic infectious conditions. The objective of this study was to evaluate the different etiologies that cause lung cavities in CTEPH patients. A retrospective data analysis of the medical records of CTEPH patients in a single reference PH center that contained or mentioned lung cavities was conducted between 2013 and 2016. Seven CTEPH patients with lung cavities were identified. The cavities had different sizes, locations, and wall thicknesses. In two patients, the cavities were attributed to pulmonary infarction; in 5 patients, an infectious etiology was identified. Despite the possibility of being solely associated with chronic lung parenchyma ischemia, most cases of lung cavities in CTEPH patients were associated with chronic granulomatous diseases, reinforcing the need for active investigation of infectious agents in this setting.